iso4217:GBP xbrli:pure xbrli:shares iso4217:GBP xbrli:shares SC049527 2025-11-30 SC049527 2024-11-30 SC049527 2024-12-01 2025-11-30 SC049527 2023-12-01 2024-11-30 SC049527 bus:Micro-entities 2024-12-01 2025-11-30 SC049527 bus:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 SC049527 bus:FilletedAccounts 2024-12-01 2025-11-30 SC049527 bus:SmallCompaniesRegimeForAccounts 2024-12-01 2025-11-30 SC049527 bus:Director1 2024-12-01 2025-11-30 SC049527 2024-12-01 2025-11-30 SC049527 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30
Medlaw Properties Limited
Registration Number SC049527 (Scotland)
Filleted Unaudited Financial Statements
for the year ended 30 November 2025
Medlaw Properties Limited
Filleted Financial Statements for the year ended 30 November 2025
Balance Sheet
2025 £
2024 £
 
 
 
 
 
 
 
 
 
 
Fixed assets
7,050,342
6,770,188
Current assets
516,533
374,882
Creditors: amounts falling due within one year
(101,215)
(67,247)
Net current assets
415,318
307,635
Total assets less current liabilities
7,465,660
7,077,823
Net assets
7,465,660
7,077,823
 
 
Capital and reserves
7,465,660
7,077,823
Notes to the financial statements
1.
Employees
The average number of employees, including directors, during the year was as follows:
Employees
2
2
2.
Directors' benefits: advances, credit and guarantees
As at 30 November 2025, £5,407 (2024 - £62,374 owed by the directors) was owed to the directors. There are no fixed terms of repayment and interest is charged at the rates advised by HMRC.
For the year ended 30 November 2025, the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilties:
The member has not required the company to obtain an audit of its financial statements for the year ended 30 November 2025 in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These financial statements have been prepared in accordance with the micro-entity regime and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved and authorised for issue by the Board of Directors on 26 April 2026.
Medlaw Properties Limited
Filleted Financial Statements for the year ended 30 November 2025
Balance Sheet
_______________________
Mrs A S Melville
Director
Appendix - Additional XBRL Tags and Values
Accounting standards applied
[Current]
bus_Micro-entities
Accounts status, audited or unaudited
[Current]
bus_AuditExemptWithAccountantsReport
Accounts type
[Current]
bus_FilletedAccounts
Applicable legislation
[Current]
bus_SmallCompaniesRegimeForAccounts
Average number of employees during the period
[Prior]
2
Average number of employees during the period
[Current]
2
Balance sheet date
[Current]
30 November 2025
Date of auditor's report
[Current]
0001-01-01
Date of authorisation of financial statements for issue
[Current]
26 April 2026
Description of principal activities
[Current]
principal activity during the year was the holding of investments.
Director signing Directors' Report
[Current]
bus_Director1
Director signing financial statements
[Current]
bus_Director1
End date for period covered by report
[Current]
30 November 2025
Entity current legal or registered name
[Current]
Medlaw Properties Limited
Entity is dormant [true/false]
[Current]
false
Entity trading status
[Current]
[default]
Equity [Multiple Tags or Values]
[Current]
7,465,660
Equity [Multiple Tags or Values]
[Prior]
7,077,823
Legal form of entity
[Current]
bus_PrivateLimitedCompanyLtd
Name of entity auditors
[Current]
CT
Name of production software
[Current]
Draftworx Cloud
Start date for period covered by report
[Current]
01 December 2024
Trade creditors / trade payables [Multiple Tags or Values]
[Current]
101,215
Trade creditors / trade payables [Multiple Tags or Values]
[Prior]
67,247
UK Companies House registered number
[Current]
SC049527
Version of production software
[Current]
2026.8.0.0